NM_018010.4:c.1119G>T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_018010.4(IFT57):c.1119G>T(p.Leu373Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000203 in 1,594,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_018010.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000151 AC: 36AN: 238334Hom.: 0 AF XY: 0.000132 AC XY: 17AN XY: 128980
GnomAD4 exome AF: 0.000207 AC: 298AN: 1442600Hom.: 0 Cov.: 29 AF XY: 0.000193 AC XY: 138AN XY: 716606
GnomAD4 genome AF: 0.000164 AC: 25AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74434
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 373 of the IFT57 protein (p.Leu373Phe). This variant is present in population databases (rs200995912, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with IFT57-related conditions. ClinVar contains an entry for this variant (Variation ID: 1496622). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
not specified Uncertain:1
The c.1119G>T (p.L373F) alteration is located in exon 11 (coding exon 11) of the IFT57 gene. This alteration results from a G to T substitution at nucleotide position 1119, causing the leucine (L) at amino acid position 373 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at